Peginterferon and Dacryoadenitis acquired - from FDA reports


Dacryoadenitis acquired is reported only by a few people who take Peginterferon. We study 12,877 people who have side effects while taking Peginterferon from FDA. Among them, 2 have Dacryoadenitis acquired. Find out below who they are, when they have Dacryoadenitis acquired and more.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 21, 2018

12,877 people reported to have side effects when taking Peginterferon.
Among them, 2 people (0.02%) have Dacryoadenitis acquired


Number of reports submitted per year:

Could Peginterferon cause Dacryoadenitis acquired?

Gender of people who have Dacryoadenitis acquired when taking Peginterferon *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Dacryoadenitis acquired when taking Peginterferon *:

Top conditions involved for these people *:

  1. Hyperthyroidism (over activity of the thyroid gland): 2 people, 100.00%
  2. High Blood Pressure: 2 people, 100.00%

Top co-used drugs for these people *:

  1. Ribavirin: 2 people, 100.00%

Top other side effects for these people *:

  1. Tenderness (pain or discomfort when an affected area is touched): 2 people, 100.00%
  2. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 2 people, 100.00%
  3. Rashes (redness): 2 people, 100.00%
  4. Night Sweats (sweating in night): 2 people, 100.00%
  5. Joint Pain: 2 people, 100.00%

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you have Dacryoadenitis acquired while taking Peginterferon?


You are not alone:




Related studies

Peginterferon

Peginterferon has active ingredients of peginterferon alfa-2a; ribavirin. It is often used in hepatitis c. (latest outcomes from Peginterferon 12,966 users)

Dacryoadenitis acquired

Dacryoadenitis acquired (inflammation of the lacrimal glands acquired) has been reported by people with high blood pressure, hyperthyroidism, hepatitis c, rheumatoid arthritis, multiple sclerosis (latest reports from 33 Dacryoadenitis acquired patients).


Drugs that are associated with Dacryoadenitis acquired
Dacryoadenitis acquired (27 drugs)
Could your condition cause Dacryoadenitis acquired
Dacryoadenitis acquired (21 conditions)
Peginterferon side effects
Browse all side effects of Peginterferon
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Peginterferon and have Dacryoadenitis acquired


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.